Zurueck zur Suche

Reporte zur Charge UJ924AD

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

15Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WI 9 TX 3 CT 1 NY 1 IL 1

VAERS 2543831

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

moderat
Staat
CT
Alter
74,0
Geschlecht
M
Eingang
27.12.2022
Impfdatum
14.12.2022
Beginn
15.12.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Injection site pain Poor quality sleep

Symptomtext

Left shoulder pain with decreased ROM starting evening s/p injection. Rated pain 6-10/10. Patient unable to sleep that evening.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
Followed up with another primary care doctor next da 12/15. Referred to orthopedics, prescribed norco and prednisone taper.
Aktuelle Erkrankungen
no known
Vorgeschichte
hx CVA, GERD, gout, hypercholesteremia, hypothyroid, insomnia, anxiety and depression, insomnia
Andere Medikamente
allopurinol, carvedilol, amlodipine, aspirin, finasteride, levothyroxine, lisinopril, omeprazole, sildenafil, trazodone, venlafaxine
Allergien
penicillin, clindamycin, cefaclor
Vorherige Impfungen
-

VAERS 2510963

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

moderat
Staat
NY
Alter
74,0
Geschlecht
F
Eingang
17.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Neck pain Pain in extremity Wrong technique in product usage process

Symptomtext

Patient spouse reported on 11/17/22: " I inform you that on October 18 my wife and I received the flu vaccine and due to a bad application of the vaccine to my wife, since then she has suffered intense pain from her neck to her left arm that prevents her make any movement and it intensifies every day more"

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
Patient just notified office today and has yet to seek medical attention.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2597702

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

mild
Staat
IL
Alter
65,0
Geschlecht
M
Eingang
16.03.2023
Impfdatum
14.09.2022
Beginn
09.03.2023
Tage bis Beginn
176,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Ageusia Anosmia COVID-19 Chills Cough Fatigue Feeling hot Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sinus congestion Sinus pain Throat irritation

Symptomtext

3/9/23 that evening I had sinus congestion and pain, a little bit of a sore throat and then chills in the middle of the night. I felt like I had fever and it broke. The next morning, I still felt warm like I had a fever. It was a couple of degrees above normal. I was more congested, and throat was more sore. I took an at home COVID test and it was positive. I called the doctor. We discussed PAXLOVID and he thought because of the interaction with the medication I am on and because I am in good shape, a marathon runner, it wasn't necessary. I took TYLENOL to bring down fever and it was down by the next morning 3/11/23. I had severe fatigue on 3/10 and 3/11. My congestion started to clear. My sore throat became a lot worse. On 3/12/23 I lost about 80% of my sense of smell and taste. On 3/13/23 pretty much all symptoms were gone, except a scratchy throat and a little bit of a cough. My blood oxygen was running 97-99. My fever remained down. My sense of taste and smell have not returned. I am still tired, but not exhausted. I have not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
COVID at home tests, negative and positive
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension; Atrial Fibrillation
Andere Medikamente
Diltiazem; triamterene; telmisartan; low dose aspirin; vitamin D3; vitamin B-12; magnesium
Allergien
None
Vorherige Impfungen
-

VAERS 2488675

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

mild
Staat
TX
Alter
86,0
Geschlecht
F
Eingang
25.10.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood pressure increased Injection site bruising Injection site coldness Injection site discolouration Injection site erythema Urticaria

Symptomtext

Patient stated at the time of vaccine administered, " it felt like ice in my arm". Patient stated that she rubbed the site all the way home. Experience increased blood pressure shortly there after. Recorded a BP read of 176/76 on 10/23/2022. Patient also states large red whelp to injection site. Patient also stated that on Tuesday 10/25/2022 that the color of the injection site has turned yellow and she believes to be a deep bruise. Patient saw heath care provider on 10/24/2022 for elevated blood pressure only. Blood pressure at the time of visit on 10/24/2022 was 151/77.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
UTI
Vorgeschichte
-
Andere Medikamente
CARVEDILOL CETIRIZINE CRANBERRY CAPSULE KLONOPIN LOSARTAN MAGNESIUM METHENAMINE HIPPURATE OLOPATADINE PANTOPRAZOLE ROSUVASTATIN SPIRONALACTION VITAMIN B VITAMIN D3
Allergien
CLARITHROMYCIN CODINE NEUROMUSCULAR BLOCKERS, STEROIDAL SULFAMETHOXAZOLE TRIMETHOPRIM
Vorherige Impfungen
-

VAERS 2481618

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj924ad

mild
Staat
WI
Alter
75,0
Geschlecht
F
Eingang
18.10.2022
Impfdatum
14.10.2022
Beginn
14.10.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Diarrhoea Pyrexia

Symptomtext

Fever, chills, diarrhea

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
osteoarthritis, hypertension
Andere Medikamente
celecoxib, sertraline, tizanidine, tramadol
Allergien
codeine, penicillin
Vorherige Impfungen
-

VAERS 2477320

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

mild
Staat
TX
Alter
72,0
Geschlecht
F
Eingang
13.10.2022
Impfdatum
11.10.2022
Beginn
11.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Urticaria

Symptomtext

Patient reported via phone that she had developed welts on her upper arm from elbow to shoulder x3 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
N/A
Vorgeschichte
Asthma, allergies, high blood pressure, anaphylaxis, thyroid
Andere Medikamente
Nucala, Advair HFA, Incruse Ellipta, Diltiazem CD, valsartan, montelukast, metoprolol, levothyroxine, Eliquis,
Allergien
Doxycycline, rosuvastatin, Trelegy Ellipta, codeine
Vorherige Impfungen
-

VAERS 2477311

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

mild
Staat
TX
Alter
83,0
Geschlecht
F
Eingang
13.10.2022
Impfdatum
27.09.2022
Beginn
28.09.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling

Symptomtext

Redness and swelling on upper arm of injection lasting 5 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Upper respiratory tract infection
Vorgeschichte
High blood pressure, asthma, allergies
Andere Medikamente
Gentamicin ophthalmic solution, atorvastatin, latanoprost ophthalmic solution. dorzolamide-timolol ophthalmic solution, Trelegy Ellipta , amlodipine, montelukast, Xarelto
Allergien
Sulfonamides, penicillins, corn syrup, had similar reaction to flu vaccine in 2015, but not in the years in between
Vorherige Impfungen
Fluzone HD redness and swelling

VAERS 2503946

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

gering
Staat
WI
Alter
58,0
Geschlecht
M
Eingang
10.11.2022
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

received the fluzone hd qiv to 58 years old with no reported adverse event; Initial information received on 01-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 58 years old male patient who had received the INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Oct-2022, the patient received 0.7ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (strength, formulation was unknown, lot UJ924AD and expiry date: 30-Jun-2022) via intramuscular route in the left deltoid for Immunization. On 17-Oct-2022 the patient developed a non-serious event of received the fluzone hd qiv to 58 years old with no reported adverse event (product administered to patient of inappropriate age)(Latency: same day) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. Action taken: was not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2503945

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

gering
Staat
WI
Alter
59,0
Geschlecht
F
Eingang
10.11.2022
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

received the fluzone hd qiv to 59 years old with no reported adverse event; Initial information received on 01-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 59 years old female patient who received the fluzone hd qiv (INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE) with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Oct-2022, the patient received a dose of 0.7 ml of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (formulation, strength: unknown) lot UJ924AD, expiration date: 30-Jun-2023 via intramuscular route in the left deltoid as Immunization On 17-OCT-2022 the patient who was 59 years old received the fluzone hd qiv with no reported adverse event (product administered to patient of inappropriate age) same day following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2501865

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

gering
Staat
WI
Alter
2,0
Geschlecht
F
Eingang
08.11.2022
Impfdatum
29.10.2022
Beginn
01.11.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient is 2 years old and received a Fluzone Quad High Dose vaccine. According to CDC: Fluzone High-Dose Quadrivalent vaccine is approved only for people 65 years and older. Fluzone High-Dose Quadrivalent is not approved for people younger than 65 years or for people of any age with a history of severe allergic reaction to any influenza vaccine or to vaccine components other than eggs. Information about vaccine ingredients is located in the manufacturer?s package insert.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2501858

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

gering
Staat
WI
Alter
11,0
Geschlecht
F
Eingang
08.11.2022
Impfdatum
29.10.2022
Beginn
01.11.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient is 11 years old and received a Fluzone Quad High Dose vaccine. According to CDC: Fluzone High-Dose Quadrivalent vaccine is approved only for people 65 years and older. Fluzone High-Dose Quadrivalent is not approved for people younger than 65 years or for people of any age with a history of severe allergic reaction to any influenza vaccine or to vaccine components other than eggs. Information about vaccine ingredients is located in the manufacturer?s package insert.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2501847

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

gering
Staat
WI
Alter
59,0
Geschlecht
M
Eingang
08.11.2022
Impfdatum
29.10.2022
Beginn
01.11.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient is 59 years old and received a Fluzone Quad High Dose vaccine. According to CDC: Fluzone High-Dose Quadrivalent vaccine is approved only for people 65 years and older. Fluzone High-Dose Quadrivalent is not approved for people younger than 65 years or for people of any age with a history of severe allergic reaction to any influenza vaccine or to vaccine components other than eggs. Information about vaccine ingredients is located in the manufacturer?s package insert.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2501838

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

gering
Staat
WI
Alter
61,0
Geschlecht
F
Eingang
08.11.2022
Impfdatum
29.10.2022
Beginn
01.11.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient is 61 years old and received a Fluzone Quad High Dose vaccine. According to CDC: Fluzone High-Dose Quadrivalent vaccine is approved only for people 65 years and older. Fluzone High-Dose Quadrivalent is not approved for people younger than 65 years or for people of any age with a history of severe allergic reaction to any influenza vaccine or to vaccine components other than eggs. Information about vaccine ingredients is located in the manufacturer?s package insert.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2501772

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

gering
Staat
WI
Alter
51,0
Geschlecht
F
Eingang
08.11.2022
Impfdatum
17.10.2022
Beginn
01.11.2022
Tage bis Beginn
15,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient is 51 years old and received a Fluzone Quad High Dose vaccine. According to CDC: Fluzone High-Dose Quadrivalent vaccine is approved only for people 65 years and older. Fluzone High-Dose Quadrivalent is not approved for people younger than 65 years or for people of any age with a history of severe allergic reaction to any influenza vaccine or to vaccine components other than eggs. Information about vaccine ingredients is located in the manufacturer?s package insert.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485489

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ924AD

gering
Staat
WI
Alter
87,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
17.10.2022
Beginn
18.10.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Patient received influenza quadrivalent High Dose P-free flu vaccine in the clinic on 9/16/22. On 9/28/22 Appointment was made to come get an influenza quadrivalent High Dose P-free flu vaccine during the drive through flu clinic that was done on 10/17/22. Patient received a second dose of the influenza quadrivalent High Dose P-free flu vaccine flu vaccine on 1017/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-